Longitudinal assessment of HLA and MIC-A antibodies in uneventful pregnancies and pregnancies complicated by preeclampsia or gestational diabetes

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Küssel, Lorenz ^a   Herkner, Harald ^b   Wahrmann, Markus ^b   Eskandary, Farsad ^b   Doberer, Konstantin ^b   Binder, Julia ^a   Pateisky, Petra ^a   Zeisler, Harald ^a   Böhmig, Georg A ^b   Bond, Gregor ^b  

^a UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; HLA ANTIGEN; HLA ANTIGEN CLASS 1; MINOR HISTOCOMPATIBILITY ANTIGEN; MR1 PROTEIN, HUMAN;

ADULT; AREA UNDER THE CURVE; BLOOD; CASE CONTROL STUDY; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOLOGY; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AREA UNDER CURVE; AUTOANTIBODIES; BIOMARKERS; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; GESTATIONAL AGE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MINOR HISTOCOMPATIBILITY ANTIGENS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; ROC CURVE;

EID: 85045788349     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-13275-6     Document Type: Article

References (38)

1. Van Rood, J. J., Eernisse, J. G. & Van Leeuwen, A. Leucocyte antibodies in sera from pregnant women. Nature 181, 1735-1736 (1958).
2. Payne, R. & Rolfs, M. R. Fetomaternal leukocyte incompatibility. J Clin Invest 37, 1756-1763, https://doi.org/10.1172/JCI103768 (1958).
3. Lashley, E. E., Meuleman, T. & Claas, F. H. Beneficial or harmful effect of antipaternal human leukocyte antibodies on pregnancy outcome? A systematic review and meta-analysis. Am J Reprod Immunol 70, 87-103, https://doi.org/10.1111/aji.12109 (2013).
4. Terasaki, P. I., Mickey, M. R., Yamazaki, J. N. & Vredevoe, D. Maternal-fetal incompatibility. I. Incidence of HL-A antibodies and possible association with congenital anomalies. Transplantation 9, 538-543 (1970).
5. Agrawal, S., Pandey, M. K., Mandal, S., Mishra, L. & Agarwal, S. Humoral immune response to an allogenic foetus in normal fertile women and recurrent aborters. BMC Pregnancy Childbirth 2, 6 (2002).
6. Payne, R. The development and persistence of leukoagglutinins in parous women. Blood 19, 411-424 (1962).
7. Regan, L., Braude, P. R. & Hill, D. P. A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod 6, 294-298 (1991).
8. Nielsen, H. S. et al. The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth. J Reprod Immunol, https://doi.org/10.1016/j.jri.2010.05.006 (2010).
9. Harris, R. E. & Lordon, R. E. The association of maternal lymphocytotoxic antibodies with obstetric complications. Obstet Gynecol 48, 302-304 (1976).
10. Vives, J., Gelabert, A. & Castillo, R. HLA antibodies and period of gestation: decline in frequency of positive sera during last trimester. Tissue Antigens 7, 209-212 (1976).
11. Middelburg, R. A., Porcelijn, L., Lardy, N., Briet, E. & Vrielink, H. Prevalence of leucocyte antibodies in the Dutch donor population. Vox Sang, doi:https://doi.org/10.1111/j.1423-0410.2010.01420.x (2010).
12. Triulzi, D. J. et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 49, 1825-1835, https://doi.org/10.1111/j.1537-2995.2009.02206.x (2009).
13. Lee, J. et al. Unexplained fetal death has a biological signature of maternal anti-fetal rejection: chronic chorioamnionitis and alloimmune anti-human leucocyte antigen antibodies. Histopathology 59, 928-938, https://doi.org/10.1111/j.1365-2559.2011.04038.x (2011).
14. Lee, J. et al. A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d. PLoS One 6, e16806, https://doi.org/10.1371/journal.pone.0016806 (2011).
15. Lee, J. et al. Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection. Am J Reprod Immunol 66, 510-526, https://doi.org/10.1111/j.1600-0897.2011.01066.x (2011).
16. Lee, J. et al. Detection of anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibodymediated maternal anti-fetal rejection and spontaneous preterm delivery. Am J Reprod Immunol 70, 162-175, https://doi.org/10.1111/aji.12141 (2013).
17. Kim, E. N. et al. Placental C4d deposition is a feature of defective placentation: observations in cases of preeclampsia and miscarriage. Virchows Arch 466, 717-725, https://doi.org/10.1007/s00428-015-1759-y (2015).
18. Steinborn, A. et al. The presence of gestational diabetes is associated with increased detection of anti-HLA-class II antibodies in the maternal circulation. Am J Reprod Immunol 56, 124-134, https://doi.org/10.1111/j.1600-0897.2006.00408.x (2006).
19. Roberts, J. M. et al. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161, 1200-1204 (1989).
20. Gobl, C. S. et al. Biomarkers of endothelial dysfunction in relation to impaired carbohydrate metabolism following pregnancy with gestational diabetes mellitus. Cardiovasc Diabetol 13, 138, https://doi.org/10.1186/s12933-014-0138-3 (2014).
21. Haumonte, J. B. et al. Enhanced prevalence of plasmatic soluble MHC class I chain-related molecule in vascular pregnancy diseases. Biomed Res Int 2014, 653161, https://doi.org/10.1155/2014/653161 (2014).
22. Mincheva-Nilsson, L. et al. Placenta-derived soluble MHC class I chain-related molecules down-regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: a possible novel immune escape mechanism for fetal survival. J Immunol 176, 3585-3592 (2006).
23. Dragun, D., Philippe, A. & Catar, R. Role of non-HLA antibodies in organ transplantation. Curr Opin Organ Transplant 17, 440-445, https://doi.org/10.1097/MOT.0b013e328355f12b (2012).
24. Eskandary, F. et al. Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study. Transplantation, https://doi.org/10.1097/TP.0000000000001195 (2016).
25. Kadyrov, M., Kingdom, J. C. & Huppertz, B. Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/intrauterine growth restriction. Am J Obstet Gynecol 194, 557-563, https://doi.org/10.1016/j.ajog.2005.07.035 (2006).
26. Kadyrov, M., Schmitz, C., Black, S., Kaufmann, P. & Huppertz, B. Pre-eclampsia and maternal anaemia display reduced apoptosis and opposite invasive phenotypes of extravillous trophoblast. Placenta 24, 540-548 (2003).
27. Apps, R. et al. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 127, 26-39, https://doi.org/10.1111/j.1365-2567.2008.03019.x (2009).
28. Mor, G., Cardenas, I., Abrahams, V. & Guller, S. Inflammation and pregnancy: the role of the immune system at the implantation site. Ann N Y Acad Sci 1221, 80-87, https://doi.org/10.1111/j.1749-6632.2010.05938.x (2011).
29. Zenclussen, A. C. Adaptive immune responses during pregnancy. Am J Reprod Immunol 69, 291-303, https://doi.org/10.1111/aji.12097 (2013).
30. Lynch, A. M. & Salmon, J. E. Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications. Placenta 31, 561-567, https://doi.org/10.1016/j.placenta.2010.03.010 (2010).
31. Datema, G., van Meir, C. A., Kanhai, H. H. & van den Elsen, P. J. Pre-term birth and severe pre-eclampsia are not associated with altered expression of HLA on human trophoblasts. Am J Reprod Immunol 49, 193-201 (2003).
32. King, K. E. et al. The role of HLA antibodies in neonatal thrombocytopenia: a prospective study. Tissue Antigens 47, 206-211 (1996).
33. Roberts, J. M. & Escudero, C. The placenta in preeclampsia. Pregnancy Hypertens 2, 72-83, https://doi.org/10.1016/j.preghy.2012.01.001 (2012).
34. Apps, R., Gardner, L., Traherne, J., Male, V. & Moffett, A. Natural-killer cell ligands at the maternal-fetal interface: UL-16 binding proteins, MHC class-I chain related molecules, HLA-F and CD48. Hum Reprod 23, 2535-2548, https://doi.org/10.1093/humrep/den223 (2008).
35. Hyde, K. J. & Schust, D. J. Immunologic challenges of human reproduction: an evolving story. Fertil Steril 106, 499-510, https://doi.org/10.1016/j.fertnstert.2016.07.1073 (2016).
36. Zou, Y. & Stastny, P. The role of major histocompatibility complex class I chain-related gene A antibodies in organ transplantation. Curr Opin Organ Transplant 14, 414-418 (2009).
37. Pantham, P., Aye, I. L. & Powell, T. L. Inflammation in maternal obesity and gestational diabetes mellitus. Placenta 36, 709-715, https://doi.org/10.1016/j.placenta.2015.04.006 (2015).
38. Kuessel, L. et al. The usefulness of CYFRA 21-1 to diagnose and predict preeclampsia: a nested case-control study. BMC Pregnancy Childbirth 16, 339, https://doi.org/10.1186/s12884-016-1132-4 (2016).